Status:

COMPLETED

Open-Label Study of Diclofenac Capsules to Treat Osteoarthritis Pain

Lead Sponsor:

Iroko Pharmaceuticals, LLC

Conditions:

Osteoarthritis

Eligibility:

All Genders

40+ years

Phase:

PHASE3

Brief Summary

The purpose of this study is to evaluate the safety of Diclofenac \[Test\] Capsules for the treatment of osteoarthritis pain of the knee or hip.

Eligibility Criteria

Inclusion

  • Male or female ≥ \[greater than or equal to\] 40 years of age
  • If a participant in the previous DIC3-08-05 study, completed the study and did not discontinue for lack of efficacy or safety
  • Has a diagnosis of OA of the hip or knee with ongoing knee and/or articular hip pain
  • Is a current chronic user of nonsteroidal anti-inflammatory drugs (NSAIDs) and/or acetaminophen for his/her OA pain and is anticipated to benefit from continuous treatment with therapeutic doses of NSAIDs. A current chronic user is defined as a subject who has used these treatments for ≥ \[greater than or equal to\] 20 days of the last 30 days before screening

Exclusion

  • Has a known history of allergic reaction or clinically significant intolerance to acetaminophen, aspirin, or any nonsteroid anti-inflammatory drugs (NSAIDs), including diclofenac
  • Requires chronic use of opioid or opioid combination products to control OA pain of the knee or hip
  • Has any clinically significant unstable cardiac, respiratory, neurological, immunological, hematological, or renal disease
  • Has significant difficulties swallowing capsules or is unable to tolerate oral medication

Key Trial Info

Start Date :

January 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2013

Estimated Enrollment :

602 Patients enrolled

Trial Details

Trial ID

NCT01510912

Start Date

January 1 2012

End Date

March 1 2013

Last Update

May 9 2014

Active Locations (40)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 10 (40 locations)

1

Premier Research Group - Phoenix

Phoenix, Arizona, United States, 85027

2

Lynn Institute of the Ozarks

Little Rock, Arkansas, United States, 72205

3

Acri-Phase I, LLC

Anaheim, California, United States, 92801

4

Med Center

Carmichael, California, United States, 95608